T. Peretz

1.5k total citations
8 papers, 223 citations indexed

About

T. Peretz is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, T. Peretz has authored 8 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Genetics. Recurrent topics in T. Peretz's work include Nutrition, Genetics, and Disease (1 paper), Synthesis and biological activity (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). T. Peretz is often cited by papers focused on Nutrition, Genetics, and Disease (1 paper), Synthesis and biological activity (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). T. Peretz collaborates with scholars based in Israel, United Kingdom and Portugal. T. Peretz's co-authors include EA Rachmilewitz, Orly Zelig, Ora Paltiel, Dvorah Abeliovich, Rosalind A. Eeles, Dvorah Abeliovich, Lina Basel‐Vanagaite, Dorit Amikam, Nayanta Sodha and Luna Kadouri and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

T. Peretz

7 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Peretz Israel 4 122 78 76 67 66 8 223
Freek Manders Netherlands 8 122 1.0× 36 0.5× 114 1.5× 44 0.7× 39 0.6× 14 202
Marta Llop Spain 9 131 1.1× 79 1.0× 77 1.0× 37 0.6× 19 0.3× 22 206
Andrea Zangrando Italy 8 147 1.2× 123 1.6× 46 0.6× 95 1.4× 23 0.3× 9 303
Steven M. Foltz United States 6 140 1.1× 28 0.4× 113 1.5× 56 0.8× 46 0.7× 8 240
E. L. Woodward Sweden 8 113 0.9× 42 0.5× 33 0.4× 50 0.7× 25 0.4× 14 225
P. Yussanne United Kingdom 6 119 1.0× 27 0.3× 90 1.2× 101 1.5× 158 2.4× 7 307
Barbara Neistadt United States 5 102 0.8× 127 1.6× 89 1.2× 90 1.3× 32 0.5× 6 305
Alvin Soon Tiong Lim Singapore 9 94 0.8× 43 0.6× 39 0.5× 63 0.9× 18 0.3× 20 270
Mary McGrath United States 10 183 1.5× 53 0.7× 110 1.4× 34 0.5× 19 0.3× 19 284
Jolien De Bie Belgium 6 174 1.4× 111 1.4× 47 0.6× 52 0.8× 26 0.4× 12 273

Countries citing papers authored by T. Peretz

Since Specialization
Citations

This map shows the geographic impact of T. Peretz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Peretz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Peretz more than expected).

Fields of papers citing papers by T. Peretz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Peretz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Peretz. The network helps show where T. Peretz may publish in the future.

Co-authorship network of co-authors of T. Peretz

This figure shows the co-authorship network connecting the top 25 collaborators of T. Peretz. A scholar is included among the top collaborators of T. Peretz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Peretz. T. Peretz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ben‐Porath, Ittai, Michal Slyper, Roy Z. Granit, et al.. (2012). 318 Control of Breast Cancer Growth and Initiation by the Stem Cell-associated Transcription Factor TCF3. European Journal of Cancer. 48. S78–S78.
2.
Lotem, Michal, T. Peretz, Ekaterina Dadachova, et al.. (2011). Two phase I studies of PTI-188, a radiolabeled murine antimelanin antibody, in patients with metastatic melanoma (MM).. Journal of Clinical Oncology. 29(15_suppl). 8555–8555. 2 indexed citations
3.
Kadouri, Luna, Zsofia Kote‐Jarai, Ayala Hubert, et al.. (2008). Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers. British Journal of Cancer. 98(12). 2006–2010. 20 indexed citations
4.
Kadouri, Luna, Dani Bercovich, Yakir Rottenberg, et al.. (2008). Effect of single-nucleotide polymorphisms in the CYP19 gene on response to Letrozole among breast cancer patients. Journal of Clinical Oncology. 26(15_suppl). 22096–22096. 2 indexed citations
5.
Amikam, Dorit, Nayanta Sodha, Lina Basel‐Vanagaite, et al.. (2007). Rapid Development of Post-radiotherapy Sarcoma and Breast Cancer in a Patient with a Novel Germline ‘De-Novo’ TP53 Mutation. Clinical Oncology. 19(7). 490–493. 49 indexed citations
6.
7.
Lotem, Michal, Eitan Shiloni, Arieh Ingber, & T. Peretz. (1997). [Active specific immunotherapy of malignant melanoma].. PubMed. 133(3-4). 122–6. 3 indexed citations
8.
Abeliovich, Dvorah, et al.. (1996). Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood. 88(11). 4296–4303. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026